| Parameters |
NVP group n=24 |
EFV group n=176 |
PI group n=160 |
p† |
| Age (years)* |
43 (38-46) |
42 (38-44) |
42 (39-44) |
0.5 |
| Male gender, no. (%) |
19 (79) |
141 (80) |
131 (82) |
0.9 |
| CDC C category, no. (%) |
6 (27) |
67 (38) |
62 (39) |
0.6 |
| Former IDU, no. (%) |
20 (83) |
149 (85) |
139 (87) |
0.8 |
| Hbs Ag positive, no. (%) |
0 (0) |
2 (1.1) |
4 (3) |
0.6 |
| HCV genotype 1-4,
no. (%) |
17 (71) |
119 (68) |
102 (64) |
0.6 |
| Liver fibrosis stage ≥ F3, no. (%)† |
5 (46) |
33 (49) |
44 (57) |
0.6 |
| Cirrhosis, no. (%)† |
3 (27) |
15 (22) |
26 (33) |
0.3 |
| CD4 cell counts (cells/mm3)* |
609 (366-730) |
514 (379-660) |
483 (315-711) |
0.3 |
| Undetectable HIV viral load, no. (%) |
23 (96) |
157 (89) |
141 (88) |
0.5 |
|
